Michael Chorev mainly investigates Receptor, Parathyroid hormone, Internal medicine, Endocrinology and Biochemistry. His Receptor research is multidisciplinary, incorporating elements of Molecular biology, Hormone, Cell growth and Binding site. As part of the same scientific family, Michael Chorev usually focuses on Hormone, concentrating on Human Parathyroid and intersecting with Stereochemistry.
His Internal medicine research is multidisciplinary, incorporating perspectives in Transfection and Osteoblast. His Endocrinology study combines topics from a wide range of disciplines, such as Protease-activated receptor 2, Interleukin-21 receptor and Bone healing. His work investigates the relationship between Biochemistry and topics such as Biophysics that intersect with problems in Transmembrane domain.
The scientist’s investigation covers issues in Stereochemistry, Biochemistry, Parathyroid hormone, Receptor and Internal medicine. His Stereochemistry research incorporates elements of Amino acid, Biological activity and Peptide. His Biochemistry study combines topics in areas such as In vivo and Cell biology.
His work on Parathyroid hormone-related protein as part of general Parathyroid hormone research is often related to Parathyroid hormone receptor, thus linking different fields of science. His Receptor research includes themes of Molecular biology, Biophysics and Binding site. Within one scientific family, he focuses on topics pertaining to Endocrinology under Internal medicine, and may sometimes address concerns connected to Agonist and Antagonist.
Michael Chorev spends much of his time researching Stereochemistry, Combinatorial chemistry, Biochemistry, Peptide and Click chemistry. His studies in Stereochemistry integrate themes in fields like Biological activity and Structure–activity relationship. He focuses mostly in the field of Biochemistry, narrowing it down to matters related to CD59 and, in some cases, Cancer research.
His research in Peptide tackles topics such as Amino acid which are related to areas like Receptor. His work in Click chemistry tackles topics such as Moiety which are related to areas like Peptide bond, Azide, Methylene bridge and Peptide synthesis. His Lactam course of study focuses on Circular dichroism and Parathyroid hormone.
Michael Chorev focuses on Stereochemistry, Click chemistry, Moiety, Azide and Side chain. His work deals with themes such as Biological activity, Peptide, Helix and Protein secondary structure, which intersect with Stereochemistry. His biological study spans a wide range of topics, including Protein structure, Parathyroid hormone and Circular dichroism.
His Parathyroid hormone research is multidisciplinary, relying on both Receptor, Structural motif, Binding domain and Isobutyric acid. His Azide research focuses on Intramolecular reaction and how it relates to Methylene bridge, Cyclic peptide and Chemical synthesis. His Biochemistry study frequently links to adjacent areas such as Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Small-Molecule Inhibition of the Interaction between the Translation Initiation Factors eIF4E and eIF4G
Nathan J. Moerke;Huseyin Aktas;Han Chen;Sonia Cantel.
On the Concept of Linear Modified Retro-Peptide Structures
Murray Goodman;Michael Chorev.
Accounts of Chemical Research (1979)
Highly selective agonists for substance P receptor subtypes.
U. Wormser;R. Laufer;Y. Hart;M. Chorev.
The EMBO Journal (1986)
A dozen years of retro-inverso peptidomimetics
Michael Chorev;Murray Goodman.
Accounts of Chemical Research (1993)
Novel Dual Inhibitors of AChE and MAO Derived from Hydroxy Aminoindan and Phenethylamine as Potential Treatment for Alzheimer's Disease.
Jeffrey Sterling;Yaacov Herzig;Tamar Goren;Nina Finkelstein.
Journal of Medicinal Chemistry (2002)
Recent developments in retro peptides and proteins — an ongoing topochemical exploration
Michael Chorev;Murray Goodman.
Trends in Biotechnology (1995)
Backbone cyclization: A new method for conferring conformational constraint on peptides
C Gilon;D Halle;M Chorev;Z Selinger.
Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice
J. M. Alexander;I. Bab;I. Bab;S. Fish;R. Müller.
Journal of Bone and Mineral Research (2001)
Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonized by enkephalin.
Ralph Laufer;Uri Wormser;Zeev Y. Friedman;Chaim Gilon.
Proceedings of the National Academy of Sciences of the United States of America (1985)
Styryl compounds which inhibit EGF receptor protein tyrosine kinase
Alexander Levitzki;Chaim Gilon;Michael Chorev;Aviv Gazit.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: